Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.45 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Asset Writedowns and Impairment (2026)

Updated

Bolt Biotherapeutics' Asset Writedowns and Impairment was $808,000 in Q2 2026.

Analysis

Bolt Biotherapeutics (BOLT) Asset Writedowns and Impairment (2026) Analysis & Trends

For FY2024, Asset Writedowns and Impairment at Bolt Biotherapeutics came in at $1.47 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Bolt Biotherapeutics 6.65 Mn 6.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 808,000.00
API Access

Bolt Biotherapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BOLT&period=max&api_key=YOUR_API_KEY